المؤلفون: Tom M. Quinn, Erin E. Gaughan, Annya Bruce, Jean Antonelli, Richard O'Connor, Feng Li, Sarah McNamara, Oliver Koch, Claire MacKintosh, David Dockrell, Timothy Walsh, Kevin G. Blyth, Colin Church, Jürgen Schwarze, Cecilia Boz, Asta Valanciute, Matthew Burgess, Philip Emanuel, Bethany Mills, Giulia Rinaldi, Gareth Hardisty, Ross Mills, Emily Gwyer Findlay, Sunny Jabbal, Andrew Duncan, Sinéad Plant, Adam D.L. Marshall, Irene Young, Kay Russell, Emma Scholefield, Alastair F. Nimmo, Islom B. Nazarov, Grant C. Churchill, James S.O. McCullagh, Kourosh H. Ebrahimi, Colin Ferrett, Kate Templeton, Steve Rannard, Andrew Owen, Anne Moore, Keith Finlayson, Manu Shankar-Hari, John Norrie, Richard A. Parker, Ahsan R. Akram, Daniel C. Anthony, James W. Dear, Nik Hirani, Kevin Dhaliwal

المصدر: EBioMedicine, Vol 76, Iss , Pp 103856- (2022)

مصطلحات موضوعية: Respiratory medicine, Infectious diseases, SARS-CoV-2/COVID-19, Nafamostat mesylate, Total manuscript word count, Medicine, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352396422000408; https://doaj.org/toc/2352-3964

URL الوصول: https://doaj.org/article/30aabc317f5544bcb011f0340db28762

المؤلفون: Sinéad Plant, Karima Lundin, Helle Mölsted Alvesson

المصدر: Health, Risk & Society. 24:258-275

مصطلحات موضوعية: Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ad15a0c44c04a162e755e71111d0acd9
https://doi.org/10.1080/13698575.2022.2104221

المؤلفون: Oliver Koch, Andrew Duncan, Jean Antonelli, Timothy S. Walsh, Annya Bruce, Kay Russell, Colin Ferrett, Colin Church, James S. O. McCullagh, Jürgen Schwarze, Cecilia Boz, Giulia Rinaldi, Sinéad Plant, Gareth Hardisty, Anne Moore, Ahsan R. Akram, Kourosh Honarmand Ebrahimi, Sarah McNamara, Feng Li, Kevin G. Blyth, K. Dhaliwal, David H. Dockrell, Asta Valanciute, Ross Mills, Bethany Mills, Claire L. Mackintosh, Daniel C. Anthony, Tom Quinn, Steve P. Rannard, John Norrie, Irene Young, Keith Finlayson, Kate Templeton, Alastair F. Nimmo, Richard A. O’Connor, Erin Gaughan, Emma Scholefield, James W. Dear, Richard Parker, Andrew Owen, Philip Emanuel, Manu Shankar-Hari, Grant C. Churchill, Adam Marshall, Nik Hirani, Islom B. Nazarov, Matthew Burgess, Emily Gwyer Findlay, Sunny Jabball

المصدر: Quinn, T, Gaughan, E E, Bruce, A, Antonelli, J, O'Connor, R A, Li, F, McNamara, S, Koch, O, Mackintosh, C, Dockrell, D, Walsh, T, Blyth, K G, Church, C, Schwarze, J, Boz, C, Valanciute, A, Burgess, M, Emanuel, P, Mills, B, Rinaldi, G, Hardisty, G, Mills, R, Gwyer Findlay, E L, Jabbal, S, Duncan, A, Plant, S, Marshall, A D L, Young, I, Russell, K, Scholefield, E, Nimmo, A F, Nazarov, I B, Churchill, G C, McCullagh, J S O, Ebrahimi, K H, Ferrett, C, Templeton, K E, Rannard, S, Owen, A, Moore, A, Finlayson, K, Shankar-Hari, M, Akram, A R, Parker, R A, Dear, J W, Hirani, N & Dhaliwal, K 2022, ' Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics ', EBioMedicine . https://doi.org/10.1016/j.ebiom.2022.103856
EBioMedicine, Vol 76, Iss, Pp 103856-(2022)

مصطلحات موضوعية: Male, Medicine (General), History, Polymers and Plastics, Kaplan-Meier Estimate, Guanidines, Industrial and Manufacturing Engineering, law.invention, Randomized controlled trial, Informed consent, law, SARS-CoV-2/COVID-19, Nafamostat mesylate, Medicine, Aged, 80 and over, education.field_of_study, Anti-Inflammatory Agents, Non-Steroidal, General Medicine, Middle Aged, Viral Load, Nafamostat, Thromboelastometry, Total manuscript word count, Treatment Outcome, Anesthesia, Infectious diseases, Administration, Intravenous, Female, Half-Life, Adult, medicine.medical_specialty, Population, Drug Administration Schedule, General Biochemistry, Genetics and Molecular Biology, Immunophenotyping, Respiratory medicine, R5-920, Pharmacokinetics, Internal medicine, Humans, Business and International Management, education, Aged, Pneumonitis, SARS-CoV-2, business.industry, COVID-19, medicine.disease, Benzamidines, COVID-19 Drug Treatment, Clinical trial, Pharmacodynamics, business, Biomarkers

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d08984770a1c6b75fcf7ed0f83784327
https://doi.org/10.2139/ssrn.3958859